Metabolic Syndrome: An Updated Review on Diagnosis and Treatment for Primary Care Clinicians
In general, semaglutide (Wegovy ) and tirzepatide (Zepbound ) are FDA-approved for weight loss in people with: A BMI of 30 or higher , or A BMI of 27 or higher with at least one weight-related condition, like type 2 diabetes or high blood pressure Each medication also has additional FDA-approved uses beyond weight loss: Wegovy is also approved to reduce the risk of major cardiovascular events like heart attack and stroke in adults with cardiovascular disease
Hypersensitivity reactions, including anaphylaxis, have been reported as well
Troke RC, Tan TM, Bloom SR
Wegovy Injections (semaglutide) is a single-receptor agonist it acts on the GLP-1 receptor alone
I dont know, what do you want? Lol Hes so supportive of anything I want to do to be healthier and hes always on board to adopt it for himself